Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +74 | +6.29% | $0.00 | 1.25K | Sep 1, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$11.8K | -35 | -2.8% | $337.32 | 1.22K | Sep 1, 2024 | Direct | |
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +42 | +3.46% | $0.00 | 1.26K | Sep 1, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$6.75K | -20 | -1.59% | $337.32 | 1.24K | Sep 1, 2024 | Direct | |
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +31 | +2.51% | $0.00 | 1.27K | Sep 1, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$5.06K | -15 | -1.18% | $337.32 | 1.25K | Sep 1, 2024 | Direct | |
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +44 | +3.51% | $0.00 | 1.3K | Sep 2, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$7.08K | -21 | -1.62% | $337.32 | 1.28K | Sep 2, 2024 | Direct | |
transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +56 | +4.39% | $0.00 | 1.33K | Sep 3, 2024 | Direct | F1 |
transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | -$9.03K | -27 | -2.03% | $334.31 | 1.31K | Sep 3, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -74 | -24.83% | $0.00 | 224 | Sep 1, 2024 | Bio-Rad A Common Stock | 74 | $0.00 | Direct | F2, F3 |
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -42 | -33.33% | $0.00 | 84 | Sep 1, 2024 | Bio-Rad A Common Stock | 42 | $0.00 | Direct | F2, F4 |
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -31 | -50% | $0.00 | 31 | Sep 1, 2024 | Bio-Rad A Common Stock | 31 | $0.00 | Direct | F2, F5 |
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -44 | -100% | $0.00 | 0 | Sep 2, 2024 | Bio-Rad A Common Stock | 44 | $0.00 | Direct | F2, F6 |
transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -56 | -100% | $0.00 | 0 | Sep 3, 2024 | Bio-Rad A Common Stock | 56 | $0.00 | Direct | F2, F7 |
Id | Content |
---|---|
F1 | Shares of Class A common stock acquired on the vesting of restricted stock units. |
F2 | Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. |
F3 | On September 1, 2023, the reporting person was granted 298 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F4 | On September 1, 2022, the reporting person was granted 167 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F5 | On September 1, 2021, the reporting person was granted 122 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F6 | On September 2, 2020, the reporting person was granted 174 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F7 | On September 3, 2019, the reporting person was granted 279 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |